Dechra Pharmaceuticals (LON: DPH) (OTC: DCHPF) is in discussions with “EQT” about possible takeover offer. DPH shares have risen 36% on Friday morning in response. That seems pretty normal, as takeover bids are usually at a premium to market prices and so on. The big questions though are still to come. Firstly, will the offer actually be made? And further, is there anyone else who might like Dechra so much that they'll also make a bid? After all, two people trying to buy something does normally lead to higher prices to the sellers.
One question, obviously, is why a private equity company, that EQT, would want to buy a veterinary products company like Dechra. Well, obviously, because they think they can make money by doing so. But how, why and beyond that obvious statement? That's not something revealed as yet and given that it is a private equity deal - if one happens at all - then they don't need to tell us either. Here's your cash, goodbye is all they actually need to say. Why the AbuDhabi investment funds are interested well, that's just as passive investors in the deal if it goes through.

Dechra Pharmaceuticals share price from London Stock Exchange
Now that there's a whiff of a bid in the air it's the technicals that matter. Note that there is no formal bid as yet. But ETQ has indicated that they might be willing to offer 4,070 pence per share and what would the Dechra board think of that. And the Dechra board's response is that if you do offer that much then we'll likely recommend it to shareholders. So, now we wait and see whether a bid really is forthcoming.
So that's the first question - will the bid happen? Secondly, is there a possible profit in this? At our pixel time perhaps - there's an 8% gap between the market price and the possible bid. But there's clearly risk attached - maybe the bid won't go through so the 8% return is conditional, not certain. Finally there's the really fun part - speculation about whether someone else will want Dechra badly enough to also bid? The ETQ bid - sorry, possble bid - price will have been crafted to be just, only just, high enough to dissuade someone else. But is it really just the high enough? Or not high enough?
The real issue here is that Dechra Pharmaceuticals is obviously in play - but how many wish to enter the game and at what price?